Clinical Trial Update: Sac-TMT for Active TNBC Brain Metastases [Phase 2]

View source ↗

Summary

This update describes a Phase 2 trial of Sac-TMT for metastatic triple-negative breast cancer with brain metastases, which is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer with Brain Metastases

Drugs mentioned

• Sac-TMT

Snippet

Sponsor: Yale University | Conditions: Metastatic Triple Negative Breast Cancers | Phase 2 | Status: NOT_YET_RECRUITING